Status:
UNKNOWN
Assessment of Follicular Fluid Level of Coenzyme Q10 in Women Undergoing ICSI
Lead Sponsor:
South Valley University
Conditions:
Pregnancy Outcome
Eligibility:
FEMALE
20-40 years
Brief Summary
The aim of this study to assess the follicular fluid level of coenzyme Q10 in women undergoing intracytoplasmic sperm injection (ICSI) and its impact on pregnancy outcome.
Detailed Description
ICSI was first applied to human gametes in 1988, it was first used in cases of fertilization failure after standard IVF or when few sperm cells were available. The first pregnancies were reported in B...
Eligibility Criteria
Inclusion
- Patient age 20-42 years.
- Normal and Poor responders women undergoing ICSI procedure.
Exclusion
- Hyper responder patients as polycystic ovarian syndrome (PCOs) patients.
- Endocrine or metabolic diseases including hyperprolactinoma, hypothyroidism and hyperthyroidism, DM and adrenal disease
- Patients with severe male factor or Y chromosome abnormality.
- Patients with systemic disease such as chronic renal disease, chronic liver disease and systemic lupus disease.
- patients with uterine cavity pathology or abnormality (endometrial polyp, myoma, hyperplasia, congenital abnormality) detected by trasvaginal 3-dimentional ultrasound or office hysteroscopy.
Key Trial Info
Start Date :
September 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 10 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04515134
Start Date
September 14 2021
End Date
September 10 2022
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohamed Mohamed Atef
Alexandria, aAlexandria, Egypt, 21515